About: http://data.cimple.eu/news-article/9e7727af72ccb0c00553c6743fc2b773e917904abdecfe311cbe0362

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/9e7727af72ccb0c00553c6743fc2b773e917904abdecfe311cbe0362 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swiss pharmaceutical giant Roche said Friday it had developed an antibody test that it hopes to roll out in May to detect people previously infected with COVID-19, even those who displayed no symptoms. Roche said in a statement that it had developed the Elecsys Anti-SARS-CoV-2 immunoassay, which using a blood sample can detect antibodies to determine the body's immune reaction to the novel coronavirus that causes COVID-19. Research teams around the world have been racing to develop such so-called serology tests for the virus, known as SARS-CoV-2, that has sparked the global pandemic with more than 2.1 million infections and over 141,000 deaths. "Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms," the Roche statement pointed out. It added that such tests could also allow screening within high risk groups like healthcare workers to determine if they may already have developed a certain level of immunity, Roche said. "Once we understand more about the immunity of COVID-19, it could also help society return faster to normality," it said. Roche said it was working with the US Food and Drug Administration (FDA) to ensure "emergency use authorisation" to bring its test to market, and said it would also be made available in markets that accept the European CE-mark certification. The company said it aimed to produce tens of millions of the new test by June, and said it would subsequently "further scale up production as fast as possible." Roche said the tests can be processed using multiple models of its analysers already in use in hospitals and reference laboratories around the world. noo/nl/rl
schema:headline	Roche eyes COVID-19 antibody test launch in May
schema:mentions	Hoffmann-La Roche USA Gymnastics Medication Antibody Immune system Switzerland Food and Drug Administration Pandemic Virus Severe acute respiratory syndrome coronavirus 2 Immunoassay CE marking Serology High-throughput screening »more»
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-04-17 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software